Kursprognose für XORTX Therapeutics Inc (XRTX)XRTXXORTX Therapeutics Inc

Alphio's XRTX stock price prediction model matches the current XORTX Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.86 (+0.65%). The 1-week path is $0.84 (-1.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

XORTX Therapeutics Inc is not a good buy right now due to its significant financial losses and poor technical indicators. The stock is currently priced at $0.87, which is close to its 52-week low of $0.83, indicating weak market performance. Additionally, the RSI is at a low 24.41, suggesting the stock is oversold, but this does not guarantee a rebound. The company has reported a staggering year-to-date change of -69.47% and has a forward P/E ratio of 0.9621, indicating potential undervaluation but also reflecting ongoing financial struggles. The main risk is its negative net income, which reached -1,690,734 USD in Q2 2026, highlighting ongoing financial instability.

XORTX Therapeutics Inc (XRTX) last closed at $0.8523, losing -2.03%. These facts feed the 1-day and 1-week XRTX price prediction above.